132 related articles for article (PubMed ID: 37802294)
1. GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.
Knöpfel N; Zecchin D; Richardson H; Polubothu S; Barberan-Martin S; Cullup T; Gholam K; Heales S; Krywawych S; López-Balboa P; Muwanga-Nanyonjo N; Ogunbiyi O; Puvirajasinghe C; Solman L; Swarbrick K; Syed SB; Tahir Z; Tisdall MM; Allgrove J; Chesover AD; Aylett SE; Jacques TS; Hannan FM; Löbel U; Semple RK; Thakker RV; Kinsler VA
J Invest Dermatol; 2024 Apr; 144(4):820-832.e9. PubMed ID: 37802294
[TBL] [Abstract][Full Text] [Related]
2. Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.
Thomas AC; Zeng Z; Rivière JB; O'Shaughnessy R; Al-Olabi L; St-Onge J; Atherton DJ; Aubert H; Bagazgoitia L; Barbarot S; Bourrat E; Chiaverini C; Chong WK; Duffourd Y; Glover M; Groesser L; Hadj-Rabia S; Hamm H; Happle R; Mushtaq I; Lacour JP; Waelchli R; Wobser M; Vabres P; Patton EE; Kinsler VA
J Invest Dermatol; 2016 Apr; 136(4):770-778. PubMed ID: 26778290
[TBL] [Abstract][Full Text] [Related]
3. GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics.
Zecchin D; Knöpfel N; Gluck AK; Stevenson M; Sauvadet A; Polubothu S; Barberan-Martin S; Michailidis F; Bryant D; Inoue A; Lines KE; Hannan FM; Semple RK; Thakker RV; Kinsler VA
J Invest Dermatol; 2024 Apr; 144(4):811-819.e4. PubMed ID: 37802293
[TBL] [Abstract][Full Text] [Related]
4. Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.
Kumar A; Zastrow DB; Kravets EJ; Beleford D; Ruzhnikov MRZ; Grove ME; Dries AM; Kohler JN; Waggott DM; Yang Y; Huang Y; ; Mackenzie KM; Eng CM; Fisher PG; Ashley EA; Teng JM; Stevenson DA; Shieh JT; Wheeler MT; Bernstein JA
Am J Med Genet A; 2019 Jun; 179(6):966-977. PubMed ID: 30920161
[TBL] [Abstract][Full Text] [Related]
5. Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11.
Davies OMT; Ng AT; Tran J; Blumenthal S; Arkin LM; Nopper AJ; Cottrell CE; Garzon M; Siegel DH; Frieden IJ; Drolet BA
Pediatr Dermatol; 2022 Nov; 39(6):914-919. PubMed ID: 36440997
[TBL] [Abstract][Full Text] [Related]
6. Phakomatosis pigmentovascularis type IIb with Klippel-Trenaunay syndrome: Association with GNAQ mutation in vascular endothelial cells.
Minami Y; Okamoto T; Hirotsu Y; Amemiya K; Osada A; Tsukamoto K; Omata M; Kawamura T
J Dermatol; 2022 Dec; 49(12):e444-e445. PubMed ID: 35906786
[No Abstract] [Full Text] [Related]
7. Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation.
Jordan M; Carmignac V; Sorlin A; Kuentz P; Albuisson J; Borradori L; Bourrat E; Boute O; Bukvic N; Bursztejn AC; Chiaverini C; Delobel B; Fournet M; Martel J; Goldenberg A; Hadj-Rabia S; Mahé A; Maruani A; Mazereeuw J; Mignot C; Morice-Picard F; Moutard ML; Petit F; Pasteur J; Phan A; Whalen S; Willems M; Philippe C; Vabres P
J Invest Dermatol; 2020 May; 140(5):1106-1110.e2. PubMed ID: 31726051
[No Abstract] [Full Text] [Related]
8. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J
Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141
[TBL] [Abstract][Full Text] [Related]
9. GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma.
Liau JY; Tsai JH; Lan J; Chen CC; Wang YH; Lee JC; Huang HY
Virchows Arch; 2020 Mar; 476(3):475-481. PubMed ID: 31707589
[TBL] [Abstract][Full Text] [Related]
10. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
[TBL] [Abstract][Full Text] [Related]
11. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
[TBL] [Abstract][Full Text] [Related]
12. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
[TBL] [Abstract][Full Text] [Related]
13. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
[TBL] [Abstract][Full Text] [Related]
14. Uveal Melanoma:
Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
[TBL] [Abstract][Full Text] [Related]
15. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
17. Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.
Tenhola S; Voutilainen R; Reyes M; Toiviainen-Salo S; Jüppner H; Mäkitie O
Eur J Endocrinol; 2016 Sep; 175(3):211-8. PubMed ID: 27334330
[TBL] [Abstract][Full Text] [Related]
18. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma.
Ayturk UM; Couto JA; Hann S; Mulliken JB; Williams KL; Huang AY; Fishman SJ; Boyd TK; Kozakewich HP; Bischoff J; Greene AK; Warman ML
Am J Hum Genet; 2016 Apr; 98(4):789-95. PubMed ID: 27058448
[TBL] [Abstract][Full Text] [Related]
19. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
Shirley MD; Tang H; Gallione CJ; Baugher JD; Frelin LP; Cohen B; North PE; Marchuk DA; Comi AM; Pevsner J
N Engl J Med; 2013 May; 368(21):1971-9. PubMed ID: 23656586
[TBL] [Abstract][Full Text] [Related]
20. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
Nesbit MA; Hannan FM; Howles SA; Babinsky VN; Head RA; Cranston T; Rust N; Hobbs MR; Heath H; Thakker RV
N Engl J Med; 2013 Jun; 368(26):2476-2486. PubMed ID: 23802516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
